fosaprepitant dimeglumine

Generic: fosaprepitant dimeglumine

Labeler: eugia us llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fosaprepitant dimeglumine
Generic Name fosaprepitant dimeglumine
Labeler eugia us llc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

fosaprepitant dimeglumine 150 mg/5mL

Manufacturer
Eugia US LLC

Identifiers & Regulatory

Product NDC 55150-299
Product ID 55150-299_37cc990f-95d3-42f3-8a13-aea0b1c7803b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210625
Listing Expiration 2026-12-31
Marketing Start 2021-01-12

Pharmacologic Class

Classes
cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 3a4 inhibitors [moa] neurokinin 1 antagonists [moa] substance p/neurokinin-1 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55150299
Hyphenated Format 55150-299

Supplemental Identifiers

RxCUI
1731077
UNII
D35FM8T64X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fosaprepitant dimeglumine (source: ndc)
Generic Name fosaprepitant dimeglumine (source: ndc)
Application Number ANDA210625 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 150 mg/5mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-299-01) / 5 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

55150-299-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-299-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

fosaprepitant dimeglumine (150 mg/5mL)

Linked Drug Pages (1)

FOSAPREPITANT DIMEGLUMINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "37cc990f-95d3-42f3-8a13-aea0b1c7803b", "openfda": {"unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["19919480-960b-4741-9611-c133d68512f5"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-299-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-299-01", "marketing_start_date": "20210112"}], "brand_name": "FOSAPREPITANT DIMEGLUMINE", "product_id": "55150-299_37cc990f-95d3-42f3-8a13-aea0b1c7803b", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "55150-299", "generic_name": "FOSAPREPITANT DIMEGLUMINE", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FOSAPREPITANT DIMEGLUMINE", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA210625", "marketing_category": "ANDA", "marketing_start_date": "20210112", "listing_expiration_date": "20261231"}